The Seattle Structural Genomics Center for Infectious Disease (SSGCID) is a consortium of researchers at Seattle BioMed, Emerald BioStructures, the University of Washington and Pacific Northwest National Laboratory that was established to apply structural genomics approaches to drug targets from infectious disease organisms. The SSGCID is currently funded over a fiveâyear period by the National Institute of Allergy and Infectious Diseases (NIAID) to determine the threeâdimensional structures of 400 proteins from a variety of Category A, B and C pathogens. Target selection engages the infectious disease research and drugâtherapy communities to identify drug targets, essential enzymes, virulence factors and vaccine candidates of biomedical relevance to combat infectious diseases. The proteinâexpression systems, purified proteins, ligand screens and threeâdimensional structures produced by SSGCID constitute a valuable resource for drugâdiscovery research, all of which is made freely available to the greater scientific community. This issue of Acta Crystallographica Section F, entirely devoted to the work of the SSGCID, covers the details of the highâthroughput pipeline and presents a series of structures from a broad array of pathogenic organisms. Here, a background is provided on the structural genomics of infectious disease, the essential components of the SSGCID pipeline are discussed and a survey of progress to date is presented.